Enhancing citizen engagement in cancer screening through deliberative democracy

Journal of the National Cancer Institute

Volumn 105, Issue 6, 2013, Pages 380-386

  Rychetnik, Lucie ^a,b   Carter, Stacy M ^b   Abelson, Julia ^c   Thornton, Hazel ^d   Barratt, Alexandra ^a   Entwistle, Vikki A ^e   MacKenzie, Geraldine ^f   Salkeld, Glenn ^a   Glasziou, Paul ^a,g  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Centre for Values   (Australia)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

^f UTas   (Australia)

^g BOND UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER SCREENING; COLORECTAL CANCER; HEALTH BEHAVIOR; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; INTESTINE CANCER; MAMMOGRAPHY; POLITICAL SYSTEM; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; UTERINE CERVIX CANCER;

ACCESS TO INFORMATION; ADULT; AUSTRALIA; BREAST NEOPLASMS; CONSUMER PARTICIPATION; DEMOCRACY; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH POLICY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INFORMATION DISSEMINATION; MALE; MAMMOGRAPHY; MIDDLE AGED; NEW ZEALAND; PERSUASIVE COMMUNICATION; POLICY MAKING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PUBLIC HEALTH; PUBLIC OPINION; SOCIAL JUSTICE;

EID: 84875626979     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs649     Document Type: Review

References (109)

1. Paul C, Nicholls R, Priest P, McGee R. Making policy decisions about population screening for breast cancer: The role of citizens' deliberation. Health Policy. 2008;85(3):314-320.
2. Woloshin S, Schwartz LM. The benefits and harms of mammography screening: understanding the trade-offs. JAMA. 2010;303(2):164-165.
3. Hoffman RM, Lewis CL, Pignone MP, et al. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making. 2010;30:53s-64s.
4. The Jefferson Center. Citizens Jury Process. http://www.jefferson-center. org/. Accessed May 17, 2012.
5. Gregory J, Hartz-Karp J, Watson R. Using deliberative techniques to engage the community in policy development. Aust New Zealand Health Policy. 2008;5:16. doi:10.1186/1743-8462-5-16
6. Smith G, Wales C. The theory and practice of citizens' juries. Policy & Politics 1999;27(3): 295-308.
7. Agency for Healthcare Research and Quality. Using Deliberative Methods to Engage Patients, Consumers and the Public. http://effectivehealthcare.ahrq. gov/index.cfm/slide-presentation-deliberative-methods/transcript- usingdeliberative- methods-webinar/. Accessed April 17, 2012.
8. Blacksher E, Diebel A, Pierre-Gerlier F, Dorr Goold S, Abelson J. What is public deliberation?. Hastings Cent Rep. 2012;42(2):14-16.
9. Goodin RE, Dryzek JS. Deliberative impacts: the macro-political uptake of mini-publics. Politics & Society. 2006;34(2):219-244.
10. Lukensmeyer CJ, Hasselblad Torres L. Public Deliberation: A Manager's Guide to Citizen Engagement: IBM Center for the Business of Government; 2006. http://www.whitehouse.gov/files/documents/ostp/opengov-inbox/ibmpubdelib.pdf (accessed 14 January 2013).
11. Sheedy A, MacKinnon MP, Pitre S, Watling J. Handbook on Citizen Engagement: Beyond Consultation. Canadian Policy Research Networks; 2008. http://www.cprn.org/documents/49583-EN.pdf (accessed 14 January 2013).
12. Bombard Y, Abelson J, Simeonov D, Gauvin FP. Eliciting ethical and social values in health technology assessment: A participatory approach. Soc Sci Med. 2011;73(1):135-144.
13. National Institute for Health and Clinical Excellence. About NICE: Citizens Council. http://www.nice.org.uk/aboutnice/howwework/citizenscouncil/ citizens-council.jsp. Accessed May 2, 2012.
14. Abelson J, Giacomini M, Lehoux P, Gauvin FP. Bringing "the public" into health technology assessment and coverage policy decisions: from principles to practice. Health Policy. 2007;82(1):37-50.
15. European Network for Health Technology Assessment. HTA Core Model for Screening Technologies. http://www.eunethta.eu/upload/WP4/Public%20consultation/ HTA-Screening-model-2nd%20public%20 draft.pdf. Accessed March 29, 2012.
16. Dorr Goold S, Neblo MA, Kim SYH, et al. What is good public deliberation? 2012. Hastings Cent. Rep. 2012;42(2):24-26.
17. Solomon S, Abelson J. Why and when should we use public deliberation? Hastings Cent Rep. 2012;42(2):17-20.
18. Bodenheimer T. The Oregon health plan-lessons for the nation. N Engl J Med. 1997;337(9):651-656.
19. O'Doherty K, Gauvin FP, Grogan C, Friedman W. Implementing a public deliberative forum. Hastings Cent Rep. 2012;42(1):20-23.
20. Parkin L, Paul C. Public good, personal privacy: a citizens' deliberation about using medical information for pharmacoepidemiological research. J Epidemiol Community Health. 2011;65(2):150-156.
21. Agency for Healthcare Research and Quality. AHRQ Community Forum. http://effectivehealthcare.ahrq.gov/index.cfm/who-is-involved-in-the- effectivehealth- care-program1/ahrq-community-forum/. Accessed October 31, 2012.
22. Abelson J, Warren M, Forest P-G. The future of public deliberation on health issues. Hastings Cent Rep. 2012;42(2):27-29.
23. Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA. 2012;307(15):1583-1584.
24. Patient Centered Outcomes Research Institute. Patient-Centered Outcomes Research. http://www.pcori.org/what-we-do/pcor/. Accessed October 29, 2012.
25. Ashcroft R. Fair process and the redundancy of bioethics: a polemic. Public Health Ethics. 2008;1(1):3.
26. McIver S. Healthy Debate: Independent Evaluation of Citizens' Juries in Health Settings. London: The Kings Fund; 1998.
27. Gastil J, Black LW, Deess EP, Leighter J. From group member to democratic citizen: how deliberating with fellow jurors reshapes civic attitudes. Hum Commun Res. 2008;34(1):137-169.
28. Chapman S, Barratt A, Stockler M. Let sleeping dogs lie? What men should know before getting tested for prostate cancer. Sydney: Sydney University Press; 2010. http://ses.library.usyd.edu.au/bitstream/2123/6835/3/Letsleeping- dogs-lie.pdf. Accessed March 28, 2012.
29. Scan Directory.com. Why Get a Scan? http://www.scandirectory.com/content/ why-get-a-body-scan.asp. Accessed April 17, 2012.
30. Jacobsen KK, von Euler-Chelpin M. Performance indicators for participation in organized mammography screening. J Public Health. 2012;34(2):272-278.
31. Gigerenzer G, Mata J, Frank R. Public knowledge of benefits of breast and prostate cancer screening in Europe. J Natl Cancer Inst. 2009;101(17):1216- 1220.
32. Schwartz LM, Woloshin S, Fowler FJ, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78.
33. Wegwarth O, Schwartz LM, Woloshin S, Gaissmaier W, Gigerenzer G. Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med. 2012;156(5):340-349.
34. Willis E. The prostatic imperative and the social relations of medical technology. Int J Technol Assess Health Care. 1997;13(4):602-612.
35. Faulkner A. Resisting the screening imperative: patienthood, populations and politics in prostate cancer detection technologies for the UK. Sociol Health Illn. 2012;34(2):221-233.
36. Newman TB, Kohn MA. Screening tests. Evidence-based diagnosis. New York: Cambridge University Press; 2009:116-137.
37. Cole A. UK patients are given advice on private screening. BMJ. 2010;341:c5394. doi:http://dx.doi.org/10.1136/bmj.c5394.
38. Tanne JH. New recommendations on mammography and cervical cancer screening disrupt US health reform debate. BMJ. 2009;339:b5012. doi:http://dx.doi.org/10.1136/bmj.b5012.
39. Raffle A, Gray M. Screening: Evidence and Practice. Oxford: Oxford University Press; 2007.
40. Fletcher SW. Breast cancer screening: a 35-year perspective. Epidemiol Rev. 2011;33(1):165-175.
41. Armstrong N, Eborall H. The sociology of medical screening: past, present and future. Sociol Health Illn. 2012;34(2):161-176.
42. Gotzsche PC. Mammography Screening: Truth, Lies and Controversy: London: Radcliffe Publishing; 2012.
43. Kalager M, Adami H-O, Bretthauer M, Tamimi RM. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med. 2012;156(7):491-499.
44. Schwartz LM, Woloshin S. Endless screenings don't bring everlasting health. New York Times. April 16, 2012:D5.
45. Cooper CP, Merritt TL, Ross LE, John LV, Jorgensen CM. To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test. Prev Med. 2004;38(2):182-191.
46. Gotzsche PC, Hartling OJ, Nielsen M, Brodersen J, Jorgensen KJ. Breast screening: the facts or maybe not. BMJ. 2009;338:b86. doi:http://dx.doi. org/10.1136/bmj.b86.
47. Baum M, Thornton H, Gotzsche PC, et al. Breast cancer awareness month. Still awaiting screening facts. BMJ. 2010;341:c6152. doi:http://dx.doi. org/10.1136/bmj.c6152.
48. Mayor S. Critics attack new NHS breast screening leaflet for failing to address harms. BMJ. 2010;341:c7267. doi:http://dx.doi.org/10.1136/bmj. c7267.
49. Elmore JG, Fletcher SW. Overdiagnosis in breast cancer screening: time to tackle an underappreciated harm. Ann Intern Med. 2012;157(7): 536-537.
50. Blake DR, Weber BM, Fletcher KE. Adolescent and young adult women's misunderstanding of the term pap smear. Arch Pediatr Adolesc Med. 2004;158(10):966-970.
51. Breitkopf CR, Pearson HC, Breitkopf DM. Poor knowledge regarding the pap test among low-income women undergoing routine screening. Perspect Sex Reprod Health. 2005;37(2):78-84.
52. Irwig L, Glasziou P. Informed consent for screening by community sampling. Eff Clin Pract. 2000;3(1):47-50.
53. Irwig L, McCaffery K, Salkeld G, Bossuyt P. Screening and choice- informed choice for screening: implications for evaluation. BMJ. 2006;332(7550):1148-1150.
54. Schwartz PH, Meslin EM. The ethics of information: absolute risk reduction and patient understanding of screening. J Gen Intern Med. 2008;23(6):867-870.
55. Jepson RG, Hewison J, Thompson A, Weller D. Patient perspectives on information and choice in cancer screening: a qualitative study in the UK. Soc Sci Med. 2007;65(5):890-899.
56. Entwistle VA, Carter SM, Trevena L, et al. Communicating about screening. BMJ. 2008;337(7673):3.
57. Stefanek ME. Uninformed compliance or informed choice? A needed shift in our approach to cancer screening. J Natl Cancer Inst. 2011;103(24): 1821-1826.
58. Krist AH, Woolf SH, Johnson RE, Kerns JW. Patient education on prostate cancer screening and involvement in decision making. Ann Fam Med. 2007;5(2):112-119.
59. Woolf SH, Krist A. The liability of giving patients a choice: shared decision making and prostate cancer. Am Fam Physician. 2005;71(10):1871-1872.
60. Levinson W, Kao A, Kuby A, Thisted RA. Not all patients want to participate in decision making-a national study of public preferences. J Gen Intern Med. 2005;20(6):531-535.
61. Juth N, Munthe C. The Ethics of Screening in Health Care and Medicine: Serving Society or Serving the Patient? International Library of Ethics, Law, and the New Medicine, Volume 51. Berlin: Springer; 2012.
62. Welch BM, Schwartz L, Woloshin S. Overdiagnosed: Making People Sick in the Pursuit of Health. Boston: Beacon Press; 2011.
63. Thorner RM, Remein QR. Principles and Procedures in the Evaluation of Screening for Disease. Public Health Monograph no. 67 (Public Health Service publication no. 846). Washington, DC: Government Printing Office; 1961.
64. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva: World Health Organization; 1968.
65. Rose G, Barker DJP. Epidemiology for the uninitiated: screening. BMJ. 1978;2:1417. doi:http://dx.doi.org/10.1136/bmj.2.6149.1417.
66. Moyer VA. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2): 120-134.
67. Welch HG, Schwartz LM, Woloshin S. Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers. BMJ. 2006;332(7543):727.
68. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2009;4:CD001877.
69. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778- 1786.
70. Marshall KG. Prevention. How much harm? How much benefit? 4. The ethics of informed consent for preventive screening programs. Can Med Assoc J. 1996;155(4):377-383.
71. Silvestre MAA, Dans LF, Dans AL. Trade-off between benefit and harm is crucial in health screening recommendations. Part II: evidence summaries. J Clin Epidemiol. 2011;64(3):240-249.
72. Dans LF, Silvestre MA, Dans AL. Trade-off between benefit and harm is crucial in health screening recommendations. Part I: general principles. J Clin Epidemiol. 2011;64(3):231-239.
73. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med. 2007;146(7):502-510.
74. Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370(9586):485-492.
75. Thorat MA. Should we undertake an MRI breast screening trial? Lancet. 2007;370(9603):1902.
76. Thornton H. Should we undertake an MRI breast screening trial? The Lancet. 2007;370(9603):1903.
77. Kuhl C, Bieling HB, Wardelmann E, Kuhn W, Schild HH. MRI breast screening? Authors' reply. Lancet. 2008;371(9622):1416.
78. Braun V, Gavey N. "With the best of reasons": cervical cancer prevention policy and the suppression of sexual risk factor information. Soc Sci Med. 1999;48(10):1463-1474.
79. Raffle AE. Information about screening-is it to achieve high uptake or to ensure informed choice? Health Expect. 2001;4(2):92-98.
80. Evans I, Thornton H, Chalmers I, Glasziou P. Earlier is not necessarily better. In:Testing Treatments: Better Research for Better Healthcare . 2nd ed. London: Pinter & Martin Ltd; 2011:31-49.
81. Connolly T, Reb J. Regret in cancer-related decisions. Health Psychol. 2005;24(4):S29-S34.
82. Howson A. Cervical screening, compliance and moral obligation. Sociol Health Illn. 1999;21(4):401-425.
83. Powers M, Faden R. Social Justice: The Moral Foundations of Public Health and Health Policy. Oxford: Oxford University Press; 2006.
84. National Health Committee. Screening to Improve Health in New Zealand: Criteria to Assess Screening Programmes. http://www.nhc.govt.nz. Accessed January 18, 2011.
85. UK National Screening Committee. Programme Appraisal Criteria: Criteria for Appraising the Viability, Effectiveness and Appropriateness of a Screening Programme. http://www.screening.nhs.uk/criteria. Accessed January 18, 2011.
86. US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual. AHRQ Publication No. 08-05118-EF. http://www. uspreventiveservicestaskforce.org/uspstf08/methods/procmanual.htm. Accessed January 18, 2011.
87. Harris R. Overview of screening: where we are and where we may be headed. Epidemiol Rev. 2011;33(1):1-6.
88. Currow D, Armstrong B. PSA Needs Order. http://www.mjainsight.com. au/view?post=david-currow-bruce-armstrong-psa-needs-order&post-id= 6489&cat=comment. Accessed May 25, 2012.
89. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716.
90. US Preventive Services Task Force. Screening for Cervical Cancer, US Preventive Services Task Force Recommendation Statement. http://www. uspreventiveservicestaskforce.org/uspstf11/cervcancer/cervcancerrs. htm#clinical. Accessed April 4, 2012.
91. Brett AS, Ablin RJ. Prostate-cancer screening-what the US Preventive Services Task Force left out. N Engl J Med. 2011;365:1949-1951 doi: 10.056/NEJMp1112191.
92. Catalona WJ, D'Amico AV, Fitzgibbons WF, et al. What the US Preventive Services Task Force missed in its prostate cancer screening recommendation. Ann Intern Med. 2012;157(2):137-138.
93. Yamey G, Wilkes M. The PSA storm: questioning cancer screening can be a risky business in America. BMJ. 2002;324(7334):431.
94. Ablin RJ. The great prostate mistake. New York Times. March 10, 2010:A27.
95. Ablin RJ, Haythorn MR. Screening for prostate cancer: controversy? What controversy? Curr Oncol. 2009;16(3):1-2.
96. Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2011;155(11):762-771.
97. Schröder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 Years of follow-up. N Engl J Med. 2012;366(11):981-990.
98. Schröder FH. Stratifying risk-the US Preventive Services Task Force and prostate-cancer screening. N Engl J Med. 2011;365:1953-1955.
99. McNaughton-Collins MF, Barry MJ. One man at a time-resolving the PSA controversy. N Engl J Med. 2011;365:1951-1953 doi: 10.056/NEJMp11112140.
100. McPherson K. Screening for breast cancer: balancing the debate. BMJ. 2010;340:c3106. doi:http://dx.doi.org/10.1136/bmj.c3106.
101. Javitt MC, Hendrick RE. Revealing Oz behind the curtain: USPSTF screening mammography guidelines and the hot air balloon. Am J Roentgenol. 2010;194(2):289-290.
102. Baum M. Breast screening should be scrapped. Evidence points to the fact that cancer mortality rates are dropping due to improved treatment, not mammograms. The Guardian. August 2, 2011. http://www.guardian.co.uk/ commentisfree/2011/aug/02/breast-cancer-screening. Accessed January 8, 2013.
103. Bock K, Borisch B, Cawson J, et al. Effect of population based screening on breast cancer mortality. Lancet. 2011;378(9805):1775-1776
104. Roder DM, Olver IN. Opposing views: do the benefits of screening mammography outweigh the harms: yes. Med J Aust. 2012;196(1):16.
105. Bell RJ, Burton RC. Opposing views: do the benefits of screening mammography outweigh the harms: no. Med J Aust. 2012;169(1):17.
106. Thier SO. Breast cancer screening: a view from outside the controversy. N Engl J Med. 1977;275(19):1063-1065.
107. Kolata G. Get a mammogram. No don't. Repeat. New York Times. November 21, 2009:WK4.
108. Slovic P. Trust, emotion, sex, politics, and science: surveying the riskassessment battlefield. Risk Anal. 1999;19(4):689-701.
109. Flitcroft K, Gillespie J, Salkeld G, Carter S, Trevena L. Getting evidence into policy: the need for deliberative strategies? Soc Sci Med. 2011;72(7):1039-1046.